nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—Injection site inflammation—Thiotepa—sarcoma	0.0416	0.0416	CcSEcCtD
Cefotaxime—Induration—Etoposide—sarcoma	0.0223	0.0223	CcSEcCtD
Cefotaxime—Local reaction—Mitoxantrone—sarcoma	0.0217	0.0217	CcSEcCtD
Cefotaxime—Encephalopathy—Thiotepa—sarcoma	0.0216	0.0216	CcSEcCtD
Cefotaxime—Nephropathy toxic—Mitoxantrone—sarcoma	0.0209	0.0209	CcSEcCtD
Cefotaxime—Nephropathy toxic—Etoposide—sarcoma	0.0174	0.0174	CcSEcCtD
Cefotaxime—Injection site inflammation—Epirubicin—sarcoma	0.0168	0.0168	CcSEcCtD
Cefotaxime—Injection site inflammation—Doxorubicin—sarcoma	0.0155	0.0155	CcSEcCtD
Cefotaxime—Bullous eruption—Epirubicin—sarcoma	0.0141	0.0141	CcSEcCtD
Cefotaxime—Colitis—Thiotepa—sarcoma	0.0133	0.0133	CcSEcCtD
Cefotaxime—Bullous eruption—Doxorubicin—sarcoma	0.0131	0.0131	CcSEcCtD
Cefotaxime—Aplastic anaemia—Dactinomycin—sarcoma	0.0129	0.0129	CcSEcCtD
Cefotaxime—Local reaction—Epirubicin—sarcoma	0.0101	0.0101	CcSEcCtD
Cefotaxime—Candida infection—Etoposide—sarcoma	0.00952	0.00952	CcSEcCtD
Cefotaxime—Local reaction—Doxorubicin—sarcoma	0.00935	0.00935	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.00901	0.00901	CcSEcCtD
Cefotaxime—Neutropenia—Dactinomycin—sarcoma	0.00809	0.00809	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00764	0.00764	CcSEcCtD
Cefotaxime—Renal failure—Thiotepa—sarcoma	0.00764	0.00764	CcSEcCtD
Cefotaxime—Jaundice—Thiotepa—sarcoma	0.00757	0.00757	CcSEcCtD
Cefotaxime—Agranulocytosis—Thiotepa—sarcoma	0.00725	0.00725	CcSEcCtD
Cefotaxime—Neutropenia—Vincristine—sarcoma	0.00722	0.00722	CcSEcCtD
Cefotaxime—Agranulocytosis—Dactinomycin—sarcoma	0.0072	0.0072	CcSEcCtD
Cefotaxime—Neutropenia—Mitoxantrone—sarcoma	0.00704	0.00704	CcSEcCtD
Cefotaxime—Haemoglobin—Thiotepa—sarcoma	0.00701	0.00701	CcSEcCtD
Cefotaxime—Haemorrhage—Thiotepa—sarcoma	0.00697	0.00697	CcSEcCtD
Cefotaxime—Hepatitis—Dactinomycin—sarcoma	0.00692	0.00692	CcSEcCtD
Cefotaxime—Liver injury—Epirubicin—sarcoma	0.00665	0.00665	CcSEcCtD
Cefotaxime—Renal failure—Mitoxantrone—sarcoma	0.0066	0.0066	CcSEcCtD
Cefotaxime—Erythema multiforme—Dactinomycin—sarcoma	0.00654	0.00654	CcSEcCtD
Cefotaxime—Jaundice—Mitoxantrone—sarcoma	0.00654	0.00654	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00652	0.00652	CcSEcCtD
Cefotaxime—Agranulocytosis—Mitoxantrone—sarcoma	0.00626	0.00626	CcSEcCtD
Cefotaxime—Arrhythmia—Thiotepa—sarcoma	0.00623	0.00623	CcSEcCtD
Cefotaxime—Bronchospasm—Etoposide—sarcoma	0.00616	0.00616	CcSEcCtD
Cefotaxime—Liver injury—Doxorubicin—sarcoma	0.00615	0.00615	CcSEcCtD
Cefotaxime—Haemoglobin—Mitoxantrone—sarcoma	0.00605	0.00605	CcSEcCtD
Cefotaxime—Hepatitis—Mitoxantrone—sarcoma	0.00602	0.00602	CcSEcCtD
Cefotaxime—Haemorrhage—Mitoxantrone—sarcoma	0.00602	0.00602	CcSEcCtD
Cefotaxime—Neutropenia—Etoposide—sarcoma	0.00585	0.00585	CcSEcCtD
Cefotaxime—Vaginal inflammation—Epirubicin—sarcoma	0.00559	0.00559	CcSEcCtD
Cefotaxime—Ill-defined disorder—Dactinomycin—sarcoma	0.00559	0.00559	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00553	0.00553	CcSEcCtD
Cefotaxime—Renal failure—Etoposide—sarcoma	0.00549	0.00549	CcSEcCtD
Cefotaxime—Jaundice—Etoposide—sarcoma	0.00544	0.00544	CcSEcCtD
Cefotaxime—Leukopenia—Thiotepa—sarcoma	0.00543	0.00543	CcSEcCtD
Cefotaxime—Malaise—Dactinomycin—sarcoma	0.00543	0.00543	CcSEcCtD
Cefotaxime—Leukopenia—Dactinomycin—sarcoma	0.00539	0.00539	CcSEcCtD
Cefotaxime—Arrhythmia—Mitoxantrone—sarcoma	0.00538	0.00538	CcSEcCtD
Cefotaxime—Colitis—Epirubicin—sarcoma	0.00537	0.00537	CcSEcCtD
Cefotaxime—Candida infection—Epirubicin—sarcoma	0.00534	0.00534	CcSEcCtD
Cefotaxime—Vaginal infection—Epirubicin—sarcoma	0.00528	0.00528	CcSEcCtD
Cefotaxime—Convulsion—Thiotepa—sarcoma	0.00526	0.00526	CcSEcCtD
Cefotaxime—Aplastic anaemia—Epirubicin—sarcoma	0.00525	0.00525	CcSEcCtD
Cefotaxime—Agranulocytosis—Etoposide—sarcoma	0.00521	0.00521	CcSEcCtD
Cefotaxime—Vaginal inflammation—Doxorubicin—sarcoma	0.00517	0.00517	CcSEcCtD
Cefotaxime—Discomfort—Dactinomycin—sarcoma	0.00507	0.00507	CcSEcCtD
Cefotaxime—Colitis—Doxorubicin—sarcoma	0.00497	0.00497	CcSEcCtD
Cefotaxime—Candida infection—Doxorubicin—sarcoma	0.00494	0.00494	CcSEcCtD
Cefotaxime—Vaginal infection—Doxorubicin—sarcoma	0.00488	0.00488	CcSEcCtD
Cefotaxime—Ill-defined disorder—Mitoxantrone—sarcoma	0.00486	0.00486	CcSEcCtD
Cefotaxime—Aplastic anaemia—Doxorubicin—sarcoma	0.00486	0.00486	CcSEcCtD
Cefotaxime—Thrombocytopenia—Thiotepa—sarcoma	0.00485	0.00485	CcSEcCtD
Cefotaxime—Leukopenia—Vincristine—sarcoma	0.00482	0.00482	CcSEcCtD
Cefotaxime—Thrombocytopenia—Dactinomycin—sarcoma	0.00481	0.00481	CcSEcCtD
Cefotaxime—Erythema multiforme—Etoposide—sarcoma	0.00474	0.00474	CcSEcCtD
Cefotaxime—Malaise—Mitoxantrone—sarcoma	0.00473	0.00473	CcSEcCtD
Cefotaxime—Leukopenia—Mitoxantrone—sarcoma	0.00469	0.00469	CcSEcCtD
Cefotaxime—Convulsion—Vincristine—sarcoma	0.00466	0.00466	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Epirubicin—sarcoma	0.00464	0.00464	CcSEcCtD
Cefotaxime—Convulsion—Mitoxantrone—sarcoma	0.00454	0.00454	CcSEcCtD
Cefotaxime—Discomfort—Mitoxantrone—sarcoma	0.00441	0.00441	CcSEcCtD
Cefotaxime—Anaphylactic shock—Vincristine—sarcoma	0.00439	0.00439	CcSEcCtD
Cefotaxime—Thrombocytopenia—Vincristine—sarcoma	0.0043	0.0043	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Doxorubicin—sarcoma	0.0043	0.0043	CcSEcCtD
Cefotaxime—Anaphylactic shock—Mitoxantrone—sarcoma	0.00428	0.00428	CcSEcCtD
Cefotaxime—Renal impairment—Epirubicin—sarcoma	0.00427	0.00427	CcSEcCtD
Cefotaxime—Dermatitis bullous—Epirubicin—sarcoma	0.00425	0.00425	CcSEcCtD
Cefotaxime—Pain—Thiotepa—sarcoma	0.00424	0.00424	CcSEcCtD
Cefotaxime—Shock—Mitoxantrone—sarcoma	0.00421	0.00421	CcSEcCtD
Cefotaxime—Pain—Dactinomycin—sarcoma	0.00421	0.00421	CcSEcCtD
Cefotaxime—Thrombocytopenia—Mitoxantrone—sarcoma	0.00419	0.00419	CcSEcCtD
Cefotaxime—Feeling abnormal—Thiotepa—sarcoma	0.00408	0.00408	CcSEcCtD
Cefotaxime—Feeling abnormal—Dactinomycin—sarcoma	0.00405	0.00405	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Thiotepa—sarcoma	0.00405	0.00405	CcSEcCtD
Cefotaxime—Ill-defined disorder—Etoposide—sarcoma	0.00405	0.00405	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Dactinomycin—sarcoma	0.00402	0.00402	CcSEcCtD
Cefotaxime—Renal impairment—Doxorubicin—sarcoma	0.00395	0.00395	CcSEcCtD
Cefotaxime—Urticaria—Thiotepa—sarcoma	0.00394	0.00394	CcSEcCtD
Cefotaxime—Malaise—Etoposide—sarcoma	0.00393	0.00393	CcSEcCtD
Cefotaxime—Dermatitis bullous—Doxorubicin—sarcoma	0.00393	0.00393	CcSEcCtD
Cefotaxime—Body temperature increased—Thiotepa—sarcoma	0.00392	0.00392	CcSEcCtD
Cefotaxime—Abdominal pain—Thiotepa—sarcoma	0.00392	0.00392	CcSEcCtD
Cefotaxime—Leukopenia—Etoposide—sarcoma	0.0039	0.0039	CcSEcCtD
Cefotaxime—Abdominal pain—Dactinomycin—sarcoma	0.00389	0.00389	CcSEcCtD
Cefotaxime—Body temperature increased—Dactinomycin—sarcoma	0.00389	0.00389	CcSEcCtD
Cefotaxime—Convulsion—Etoposide—sarcoma	0.00378	0.00378	CcSEcCtD
Cefotaxime—Pain—Vincristine—sarcoma	0.00376	0.00376	CcSEcCtD
Cefotaxime—Discomfort—Etoposide—sarcoma	0.00367	0.00367	CcSEcCtD
Cefotaxime—Pain—Mitoxantrone—sarcoma	0.00366	0.00366	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00366	0.00366	CcSEcCtD
Cefotaxime—Hypersensitivity—Thiotepa—sarcoma	0.00365	0.00365	CcSEcCtD
Cefotaxime—Hypersensitivity—Dactinomycin—sarcoma	0.00362	0.00362	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Vincristine—sarcoma	0.00359	0.00359	CcSEcCtD
Cefotaxime—Anaphylactic shock—Etoposide—sarcoma	0.00356	0.00356	CcSEcCtD
Cefotaxime—Feeling abnormal—Mitoxantrone—sarcoma	0.00353	0.00353	CcSEcCtD
Cefotaxime—Pruritus—Thiotepa—sarcoma	0.00351	0.00351	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Mitoxantrone—sarcoma	0.0035	0.0035	CcSEcCtD
Cefotaxime—Thrombocytopenia—Etoposide—sarcoma	0.00348	0.00348	CcSEcCtD
Cefotaxime—Eosinophilia—Epirubicin—sarcoma	0.00347	0.00347	CcSEcCtD
Cefotaxime—Abdominal pain—Vincristine—sarcoma	0.00347	0.00347	CcSEcCtD
Cefotaxime—Body temperature increased—Vincristine—sarcoma	0.00347	0.00347	CcSEcCtD
Cefotaxime—Urticaria—Mitoxantrone—sarcoma	0.0034	0.0034	CcSEcCtD
Cefotaxime—Diarrhoea—Thiotepa—sarcoma	0.00339	0.00339	CcSEcCtD
Cefotaxime—Abdominal pain—Mitoxantrone—sarcoma	0.00338	0.00338	CcSEcCtD
Cefotaxime—Body temperature increased—Mitoxantrone—sarcoma	0.00338	0.00338	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00338	0.00338	CcSEcCtD
Cefotaxime—Diarrhoea—Dactinomycin—sarcoma	0.00336	0.00336	CcSEcCtD
Cefotaxime—Neutropenia—Epirubicin—sarcoma	0.00328	0.00328	CcSEcCtD
Cefotaxime—Hypersensitivity—Vincristine—sarcoma	0.00324	0.00324	CcSEcCtD
Cefotaxime—Eosinophilia—Doxorubicin—sarcoma	0.00321	0.00321	CcSEcCtD
Cefotaxime—Hypersensitivity—Mitoxantrone—sarcoma	0.00315	0.00315	CcSEcCtD
Cefotaxime—Vomiting—Thiotepa—sarcoma	0.00315	0.00315	CcSEcCtD
Cefotaxime—Vomiting—Dactinomycin—sarcoma	0.00313	0.00313	CcSEcCtD
Cefotaxime—Rash—Thiotepa—sarcoma	0.00312	0.00312	CcSEcCtD
Cefotaxime—Dermatitis—Thiotepa—sarcoma	0.00312	0.00312	CcSEcCtD
Cefotaxime—Headache—Thiotepa—sarcoma	0.0031	0.0031	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.0031	0.0031	CcSEcCtD
Cefotaxime—Rash—Dactinomycin—sarcoma	0.0031	0.0031	CcSEcCtD
Cefotaxime—Renal failure—Epirubicin—sarcoma	0.00308	0.00308	CcSEcCtD
Cefotaxime—Jaundice—Epirubicin—sarcoma	0.00305	0.00305	CcSEcCtD
Cefotaxime—Pain—Etoposide—sarcoma	0.00304	0.00304	CcSEcCtD
Cefotaxime—Neutropenia—Doxorubicin—sarcoma	0.00304	0.00304	CcSEcCtD
Cefotaxime—Diarrhoea—Vincristine—sarcoma	0.00301	0.00301	CcSEcCtD
Cefotaxime—Nausea—Thiotepa—sarcoma	0.00294	0.00294	CcSEcCtD
Cefotaxime—Feeling abnormal—Etoposide—sarcoma	0.00293	0.00293	CcSEcCtD
Cefotaxime—Diarrhoea—Mitoxantrone—sarcoma	0.00293	0.00293	CcSEcCtD
Cefotaxime—Nausea—Dactinomycin—sarcoma	0.00292	0.00292	CcSEcCtD
Cefotaxime—Agranulocytosis—Epirubicin—sarcoma	0.00292	0.00292	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Etoposide—sarcoma	0.00291	0.00291	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00287	0.00287	CcSEcCtD
Cefotaxime—Renal failure—Doxorubicin—sarcoma	0.00285	0.00285	CcSEcCtD
Cefotaxime—Urticaria—Etoposide—sarcoma	0.00283	0.00283	CcSEcCtD
Cefotaxime—Haemoglobin—Epirubicin—sarcoma	0.00282	0.00282	CcSEcCtD
Cefotaxime—Jaundice—Doxorubicin—sarcoma	0.00282	0.00282	CcSEcCtD
Cefotaxime—Body temperature increased—Etoposide—sarcoma	0.00281	0.00281	CcSEcCtD
Cefotaxime—Abdominal pain—Etoposide—sarcoma	0.00281	0.00281	CcSEcCtD
Cefotaxime—Hepatitis—Epirubicin—sarcoma	0.00281	0.00281	CcSEcCtD
Cefotaxime—Haemorrhage—Epirubicin—sarcoma	0.00281	0.00281	CcSEcCtD
Cefotaxime—Vomiting—Vincristine—sarcoma	0.00279	0.00279	CcSEcCtD
Cefotaxime—Rash—Vincristine—sarcoma	0.00277	0.00277	CcSEcCtD
Cefotaxime—Dermatitis—Vincristine—sarcoma	0.00277	0.00277	CcSEcCtD
Cefotaxime—Headache—Vincristine—sarcoma	0.00275	0.00275	CcSEcCtD
Cefotaxime—Vomiting—Mitoxantrone—sarcoma	0.00272	0.00272	CcSEcCtD
Cefotaxime—Agranulocytosis—Doxorubicin—sarcoma	0.0027	0.0027	CcSEcCtD
Cefotaxime—Rash—Mitoxantrone—sarcoma	0.0027	0.0027	CcSEcCtD
Cefotaxime—Dermatitis—Mitoxantrone—sarcoma	0.0027	0.0027	CcSEcCtD
Cefotaxime—Headache—Mitoxantrone—sarcoma	0.00268	0.00268	CcSEcCtD
Cefotaxime—Erythema multiforme—Epirubicin—sarcoma	0.00266	0.00266	CcSEcCtD
Cefotaxime—Hypersensitivity—Etoposide—sarcoma	0.00262	0.00262	CcSEcCtD
Cefotaxime—Haemoglobin—Doxorubicin—sarcoma	0.00261	0.00261	CcSEcCtD
Cefotaxime—Nausea—Vincristine—sarcoma	0.00261	0.00261	CcSEcCtD
Cefotaxime—Hepatitis—Doxorubicin—sarcoma	0.0026	0.0026	CcSEcCtD
Cefotaxime—Haemorrhage—Doxorubicin—sarcoma	0.0026	0.0026	CcSEcCtD
Cefotaxime—Nausea—Mitoxantrone—sarcoma	0.00254	0.00254	CcSEcCtD
Cefotaxime—Pruritus—Etoposide—sarcoma	0.00252	0.00252	CcSEcCtD
Cefotaxime—Arrhythmia—Epirubicin—sarcoma	0.00251	0.00251	CcSEcCtD
Cefotaxime—Erythema multiforme—Doxorubicin—sarcoma	0.00246	0.00246	CcSEcCtD
Cefotaxime—Diarrhoea—Etoposide—sarcoma	0.00244	0.00244	CcSEcCtD
Cefotaxime—Arrhythmia—Doxorubicin—sarcoma	0.00232	0.00232	CcSEcCtD
Cefotaxime—Ill-defined disorder—Epirubicin—sarcoma	0.00227	0.00227	CcSEcCtD
Cefotaxime—Vomiting—Etoposide—sarcoma	0.00226	0.00226	CcSEcCtD
Cefotaxime—Rash—Etoposide—sarcoma	0.00224	0.00224	CcSEcCtD
Cefotaxime—Dermatitis—Etoposide—sarcoma	0.00224	0.00224	CcSEcCtD
Cefotaxime—Headache—Etoposide—sarcoma	0.00223	0.00223	CcSEcCtD
Cefotaxime—Malaise—Epirubicin—sarcoma	0.0022	0.0022	CcSEcCtD
Cefotaxime—Leukopenia—Epirubicin—sarcoma	0.00219	0.00219	CcSEcCtD
Cefotaxime—Convulsion—Epirubicin—sarcoma	0.00212	0.00212	CcSEcCtD
Cefotaxime—Nausea—Etoposide—sarcoma	0.00211	0.00211	CcSEcCtD
Cefotaxime—Ill-defined disorder—Doxorubicin—sarcoma	0.0021	0.0021	CcSEcCtD
Cefotaxime—Discomfort—Epirubicin—sarcoma	0.00206	0.00206	CcSEcCtD
Cefotaxime—Malaise—Doxorubicin—sarcoma	0.00204	0.00204	CcSEcCtD
Cefotaxime—Leukopenia—Doxorubicin—sarcoma	0.00202	0.00202	CcSEcCtD
Cefotaxime—Anaphylactic shock—Epirubicin—sarcoma	0.002	0.002	CcSEcCtD
Cefotaxime—Shock—Epirubicin—sarcoma	0.00196	0.00196	CcSEcCtD
Cefotaxime—Convulsion—Doxorubicin—sarcoma	0.00196	0.00196	CcSEcCtD
Cefotaxime—Thrombocytopenia—Epirubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Cefotaxime—Discomfort—Doxorubicin—sarcoma	0.0019	0.0019	CcSEcCtD
Cefotaxime—Anaphylactic shock—Doxorubicin—sarcoma	0.00185	0.00185	CcSEcCtD
Cefotaxime—Shock—Doxorubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Cefotaxime—Thrombocytopenia—Doxorubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Cefotaxime—Pain—Epirubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Cefotaxime—Feeling abnormal—Epirubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Epirubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Cefotaxime—Urticaria—Epirubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Cefotaxime—Pain—Doxorubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Cefotaxime—Abdominal pain—Epirubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Cefotaxime—Body temperature increased—Epirubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Cefotaxime—Feeling abnormal—Doxorubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Doxorubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Cefotaxime—Hypersensitivity—Epirubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Cefotaxime—Urticaria—Doxorubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Cefotaxime—Abdominal pain—Doxorubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Cefotaxime—Body temperature increased—Doxorubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Cefotaxime—Pruritus—Epirubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Cefotaxime—Diarrhoea—Epirubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Cefotaxime—Hypersensitivity—Doxorubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Cefotaxime—Pruritus—Doxorubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Cefotaxime—Vomiting—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Cefotaxime—Diarrhoea—Doxorubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Cefotaxime—Rash—Epirubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Cefotaxime—Dermatitis—Epirubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Cefotaxime—Headache—Epirubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Cefotaxime—Nausea—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Cefotaxime—Vomiting—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Cefotaxime—Rash—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Cefotaxime—Dermatitis—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Cefotaxime—Headache—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Cefotaxime—Nausea—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
